Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)

NCT01974687 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Uprifosbuvir
DRUG: Placebo
DRUG: Itraconazole

Sponsor

Merck Sharp & Dohme LLC